OmniAb (OABI) Current Leases (2021 - 2026)
OmniAb (OABI) reported Current Leases of $3.9 million for Q1 2026, up 3.33% year-over-year from $3.8 million in Q1 2025, and up 1.57% quarter-over-quarter from $3.9 million in Q4 2025.
OmniAb (OABI) Current Leases (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Current Leases data on file, last reported at $3.9 million in Q1 2026.
- Current Leases for Q1 2026 came in at $3.9 million, up 3.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (up 3.33% YoY), and the FY2025 annual result was $3.9 million, up 2.56% from the prior year.
- Current Leases advanced to $3.9 million in Q1 2026 per OABI's latest filing, from $3.9 million in the prior quarter.
- Over five years, Current Leases peaked at $3.9 million in Q1 2026 and troughed at $1.8 million in Q4 2022.
- A 5-year average of $3.5 million and a median of $3.7 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2025: Current Leases surged 207.96% in 2022, then grew 2.56% in 2025.
- A 5-year view of Current Leases shows it stood at $1.8 million in 2022, then jumped by 95.84% to $3.5 million in 2023, then increased by 8.49% to $3.8 million in 2024, then rose by 2.56% to $3.9 million in 2025, then climbed by 1.57% to $3.9 million in 2026.
- Business Quant data shows OABI's Current Leases at $3.9 million in Q1 2026, $3.9 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 3.88 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 3.84 Mn |
| Mar 31, 2025 | 3.81 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 3.45 Mn |
| Jun 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | 2.44 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | 578,000.00 |